company background image
PIQ

Proteomics International Laboratories ASX:PIQ Stock Report

Last Price

AU$1.14

Market Cap

AU$134.8m

7D

4.1%

1Y

2.7%

Updated

07 Feb, 2023

Data

Company Financials +

Proteomics International Laboratories Limited

ASX:PIQ Stock Report

Mkt Cap: AU$134.8m

PIQ Stock Overview

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics.

PIQ fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Proteomics International Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Proteomics International Laboratories
Historical stock prices
Current Share PriceAU$1.14
52 Week HighAU$1.35
52 Week LowAU$0.71
Beta0.90
1 Month Change4.11%
3 Month Change23.91%
1 Year Change2.70%
3 Year Change307.14%
5 Year Change307.14%
Change since IPO406.67%

Recent News & Updates

Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Nov 17
Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Recent updates

Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Nov 17
Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?

Aug 09
Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?

We Think Proteomics International Laboratories (ASX:PIQ) Can Afford To Drive Business Growth

Oct 20
We Think Proteomics International Laboratories (ASX:PIQ) Can Afford To Drive Business Growth

We're Not Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn

May 31
We're Not Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn

Why Proteomics International Laboratories' (ASX:PIQ) CEO Pay Matters

Feb 12
Why Proteomics International Laboratories' (ASX:PIQ) CEO Pay Matters

We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely

Jan 08
We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely

Is Proteomics International Laboratories' (ASX:PIQ) 172% Share Price Increase Well Justified?

Dec 04
Is Proteomics International Laboratories' (ASX:PIQ) 172% Share Price Increase Well Justified?

Shareholder Returns

PIQAU Life SciencesAU Market
7D4.1%2.0%0.4%
1Y2.7%-52.3%0.4%

Return vs Industry: PIQ exceeded the Australian Life Sciences industry which returned -49.9% over the past year.

Return vs Market: PIQ matched the Australian Market which returned 1.8% over the past year.

Price Volatility

Is PIQ's price volatile compared to industry and market?
PIQ volatility
PIQ Average Weekly Movement6.7%
Life Sciences Industry Average Movement8.7%
Market Average Movement8.4%
10% most volatile stocks in AU Market15.5%
10% least volatile stocks in AU Market3.4%

Stable Share Price: PIQ is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: PIQ's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/aRichard Lipscombehttps://www.proteomics.com.au

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research.

Proteomics International Laboratories Limited Fundamentals Summary

How do Proteomics International Laboratories's earnings and revenue compare to its market cap?
PIQ fundamental statistics
Market CapAU$134.82m
Earnings (TTM)-AU$4.97m
Revenue (TTM)AU$3.43m

39.3x

P/S Ratio

-27.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PIQ income statement (TTM)
RevenueAU$3.43m
Cost of RevenueAU$2.06m
Gross ProfitAU$1.37m
Other ExpensesAU$6.35m
Earnings-AU$4.97m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.042
Gross Margin40.01%
Net Profit Margin-144.98%
Debt/Equity Ratio0%

How did PIQ perform over the long term?

See historical performance and comparison